Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer
Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement. We...
Gespeichert in:
Veröffentlicht in: | Clinical genitourinary cancer 2024-12, Vol.22 (6), p.102241, Article 102241 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 6 |
container_start_page | 102241 |
container_title | Clinical genitourinary cancer |
container_volume | 22 |
creator | Scilipoti, Pietro Moschini, Marco de Angelis, Mario Longoni, Mattia Afferi, Luca Lonati, Chiara Zaurito, Paolo Pichler, Renate Necchi, Andrea Montorsi, Francesco Briganti, Alberto Mari, Andrea Krajewski, Wojciech Laukthina, Ekaterina Pradere, Benjamin Giudice, Francesco Del Mertens, Laura Gallioli, Andrea Soria, Francesco Gontero, Paolo Albisinni, Simone Shariat, Shahrokh F. Carando, Roberto |
description | Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement.
We retrospectively analyzed data from 1550 patients with cTa-T3NanyM0 BCa who underwent radical cystectomy (RC) between at 12 tertiary care centers (1990-2020). Patients with complete follow-up, no prior history of UUT cancer, and who required UUT decompression for preoperative hydronephrosis were selected. Hydronephrosis grade was defined according to established scoring systems. UUT recurrence was diagnosed through imaging, urinary cytology, and confirmed by selective cytology and ureteroscopy when possible. Propensity scores were computed to determine overlap weights and balance groups. Kaplan–Meier analyses estimated UUT recurrence-free survival (RFS), cancer-specific (CSS), and overall survival (OS) before and after weighting. Cox regression analyses before and after weighting were fitted to predict UUT recurrence.
Of 524 included patients, 132 (25%) and 392 (75%) patients were managed with DJS and PCN placement, respectively. Patients who received PCN had higher grade (≥ 3) of obstruction (34% vs. 14%) and pT3-4 tumors (70% vs. 36%) than patients with DJS. During a median follow-up of 19 months, 2-years UUT-RFS did not differ between groups (95% for PCN vs 92% for DJS, weighted HR 1.41, 95% CI, 0.55-3.59). There was no difference in 2-years weighted CSS (74% vs. 74%) and OS (67% vs 69%). Main limitations were the short follow-up and inclusion of patients uniquely undergoing RC.
These results suggest that ureteral DJS does not increase the risk of developing UUT recurrence in BCa patients with hydronephrosis requiring UUT decompression. However, UUT recurrence was rare, and associations were weak, with findings susceptible to bias. Randomized trials are needed to validate these results.
Our study aims to assess if UUT decompression with Double J in patients who have hydronephrosis prior to RC, can increase the risk of UUT recurrence compared to PCN. We observed no different in the risk of subsequent UUT recurrence depending on the type of UUT management strategy, however the risk of UUT recurrence was low.
[Display omitted] |
doi_str_mv | 10.1016/j.clgc.2024.102241 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3128318268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1558767324002118</els_id><sourcerecordid>3128318268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c237t-d6183ec6e8248e952f9507740139319b82f72a26c7bc6c6402f290b3cd07932b3</originalsourceid><addsrcrecordid>eNp9kE1vEzEQhi0EoqXwBzggH7lssMe7tlfiUiK-pFZUpRFHyzs72zjsR7AdJP49jlI49jT-eObVzMPYaylWUkj9brfC8R5XIKAuDwC1fMLOZatsJbSFp-XcNLYy2qgz9iKlnRB1I414zs5U24jW1OqcTbch_eTLwK8pe9zGZV4OiW_2e4r8LnrMfBOXvKUx-JGvfcQwL5Pnl0MuwCZSKeXje6Y5h_meh5nf-BzKLfEfIW_5h9H3fUHXfkaKL9mzwY-JXj3UC7b59PFu_aW6-vb56_ryqkJQJle9llYRarJQW2obGMq8xtRCqlbJtrMwGPCg0XSoUdcCBmhFp7AXplXQqQv29pS7j8uvA6XsppCQxtHPVPZzSoJV0oK2BYUTinFJKdLg9jFMPv5xUrijZrdzR83uqNmdNJemNw_5h26i_n_LP68FeH8CqGz5O1B0CYsVpD5Ewuz6JTyW_xfek41P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128318268</pqid></control><display><type>article</type><title>Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Scilipoti, Pietro ; Moschini, Marco ; de Angelis, Mario ; Longoni, Mattia ; Afferi, Luca ; Lonati, Chiara ; Zaurito, Paolo ; Pichler, Renate ; Necchi, Andrea ; Montorsi, Francesco ; Briganti, Alberto ; Mari, Andrea ; Krajewski, Wojciech ; Laukthina, Ekaterina ; Pradere, Benjamin ; Giudice, Francesco Del ; Mertens, Laura ; Gallioli, Andrea ; Soria, Francesco ; Gontero, Paolo ; Albisinni, Simone ; Shariat, Shahrokh F. ; Carando, Roberto</creator><creatorcontrib>Scilipoti, Pietro ; Moschini, Marco ; de Angelis, Mario ; Longoni, Mattia ; Afferi, Luca ; Lonati, Chiara ; Zaurito, Paolo ; Pichler, Renate ; Necchi, Andrea ; Montorsi, Francesco ; Briganti, Alberto ; Mari, Andrea ; Krajewski, Wojciech ; Laukthina, Ekaterina ; Pradere, Benjamin ; Giudice, Francesco Del ; Mertens, Laura ; Gallioli, Andrea ; Soria, Francesco ; Gontero, Paolo ; Albisinni, Simone ; Shariat, Shahrokh F. ; Carando, Roberto ; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group ; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</creatorcontrib><description>Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement.
We retrospectively analyzed data from 1550 patients with cTa-T3NanyM0 BCa who underwent radical cystectomy (RC) between at 12 tertiary care centers (1990-2020). Patients with complete follow-up, no prior history of UUT cancer, and who required UUT decompression for preoperative hydronephrosis were selected. Hydronephrosis grade was defined according to established scoring systems. UUT recurrence was diagnosed through imaging, urinary cytology, and confirmed by selective cytology and ureteroscopy when possible. Propensity scores were computed to determine overlap weights and balance groups. Kaplan–Meier analyses estimated UUT recurrence-free survival (RFS), cancer-specific (CSS), and overall survival (OS) before and after weighting. Cox regression analyses before and after weighting were fitted to predict UUT recurrence.
Of 524 included patients, 132 (25%) and 392 (75%) patients were managed with DJS and PCN placement, respectively. Patients who received PCN had higher grade (≥ 3) of obstruction (34% vs. 14%) and pT3-4 tumors (70% vs. 36%) than patients with DJS. During a median follow-up of 19 months, 2-years UUT-RFS did not differ between groups (95% for PCN vs 92% for DJS, weighted HR 1.41, 95% CI, 0.55-3.59). There was no difference in 2-years weighted CSS (74% vs. 74%) and OS (67% vs 69%). Main limitations were the short follow-up and inclusion of patients uniquely undergoing RC.
These results suggest that ureteral DJS does not increase the risk of developing UUT recurrence in BCa patients with hydronephrosis requiring UUT decompression. However, UUT recurrence was rare, and associations were weak, with findings susceptible to bias. Randomized trials are needed to validate these results.
Our study aims to assess if UUT decompression with Double J in patients who have hydronephrosis prior to RC, can increase the risk of UUT recurrence compared to PCN. We observed no different in the risk of subsequent UUT recurrence depending on the type of UUT management strategy, however the risk of UUT recurrence was low.
[Display omitted]</description><identifier>ISSN: 1558-7673</identifier><identifier>ISSN: 1938-0682</identifier><identifier>EISSN: 1938-0682</identifier><identifier>DOI: 10.1016/j.clgc.2024.102241</identifier><identifier>PMID: 39509743</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Carcinoma, Transitional Cell - pathology ; Carcinoma, Transitional Cell - surgery ; Cystectomy ; Double J ; Female ; Follow-Up Studies ; Humans ; Hydronephrosis ; Hydronephrosis - etiology ; Male ; Middle Aged ; Neoplasms, Second Primary - pathology ; Neoplasms, Second Primary - surgery ; Nephrostomy, Percutaneous ; percutaneous nephrostomy ; Radical cystectomy ; Retrospective Studies ; Stents ; Ureteral Neoplasms - pathology ; Ureteral Neoplasms - surgery ; Urinary Bladder Neoplasms - pathology ; Urinary Bladder Neoplasms - surgery ; UUT recurrence</subject><ispartof>Clinical genitourinary cancer, 2024-12, Vol.22 (6), p.102241, Article 102241</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c237t-d6183ec6e8248e952f9507740139319b82f72a26c7bc6c6402f290b3cd07932b3</cites><orcidid>0000-0003-3865-5988 ; 0000-0002-3316-5691 ; 0000-0001-5286-9048 ; 0000-0002-7768-8558 ; 0000-0002-5472-1933 ; 0000-0002-8953-0272 ; 0000-0003-3773-3171 ; 0000-0002-2613-2306</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39509743$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scilipoti, Pietro</creatorcontrib><creatorcontrib>Moschini, Marco</creatorcontrib><creatorcontrib>de Angelis, Mario</creatorcontrib><creatorcontrib>Longoni, Mattia</creatorcontrib><creatorcontrib>Afferi, Luca</creatorcontrib><creatorcontrib>Lonati, Chiara</creatorcontrib><creatorcontrib>Zaurito, Paolo</creatorcontrib><creatorcontrib>Pichler, Renate</creatorcontrib><creatorcontrib>Necchi, Andrea</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Mari, Andrea</creatorcontrib><creatorcontrib>Krajewski, Wojciech</creatorcontrib><creatorcontrib>Laukthina, Ekaterina</creatorcontrib><creatorcontrib>Pradere, Benjamin</creatorcontrib><creatorcontrib>Giudice, Francesco Del</creatorcontrib><creatorcontrib>Mertens, Laura</creatorcontrib><creatorcontrib>Gallioli, Andrea</creatorcontrib><creatorcontrib>Soria, Francesco</creatorcontrib><creatorcontrib>Gontero, Paolo</creatorcontrib><creatorcontrib>Albisinni, Simone</creatorcontrib><creatorcontrib>Shariat, Shahrokh F.</creatorcontrib><creatorcontrib>Carando, Roberto</creatorcontrib><creatorcontrib>European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</creatorcontrib><creatorcontrib>European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</creatorcontrib><title>Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer</title><title>Clinical genitourinary cancer</title><addtitle>Clin Genitourin Cancer</addtitle><description>Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement.
We retrospectively analyzed data from 1550 patients with cTa-T3NanyM0 BCa who underwent radical cystectomy (RC) between at 12 tertiary care centers (1990-2020). Patients with complete follow-up, no prior history of UUT cancer, and who required UUT decompression for preoperative hydronephrosis were selected. Hydronephrosis grade was defined according to established scoring systems. UUT recurrence was diagnosed through imaging, urinary cytology, and confirmed by selective cytology and ureteroscopy when possible. Propensity scores were computed to determine overlap weights and balance groups. Kaplan–Meier analyses estimated UUT recurrence-free survival (RFS), cancer-specific (CSS), and overall survival (OS) before and after weighting. Cox regression analyses before and after weighting were fitted to predict UUT recurrence.
Of 524 included patients, 132 (25%) and 392 (75%) patients were managed with DJS and PCN placement, respectively. Patients who received PCN had higher grade (≥ 3) of obstruction (34% vs. 14%) and pT3-4 tumors (70% vs. 36%) than patients with DJS. During a median follow-up of 19 months, 2-years UUT-RFS did not differ between groups (95% for PCN vs 92% for DJS, weighted HR 1.41, 95% CI, 0.55-3.59). There was no difference in 2-years weighted CSS (74% vs. 74%) and OS (67% vs 69%). Main limitations were the short follow-up and inclusion of patients uniquely undergoing RC.
These results suggest that ureteral DJS does not increase the risk of developing UUT recurrence in BCa patients with hydronephrosis requiring UUT decompression. However, UUT recurrence was rare, and associations were weak, with findings susceptible to bias. Randomized trials are needed to validate these results.
Our study aims to assess if UUT decompression with Double J in patients who have hydronephrosis prior to RC, can increase the risk of UUT recurrence compared to PCN. We observed no different in the risk of subsequent UUT recurrence depending on the type of UUT management strategy, however the risk of UUT recurrence was low.
[Display omitted]</description><subject>Aged</subject><subject>Carcinoma, Transitional Cell - pathology</subject><subject>Carcinoma, Transitional Cell - surgery</subject><subject>Cystectomy</subject><subject>Double J</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hydronephrosis</subject><subject>Hydronephrosis - etiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Neoplasms, Second Primary - surgery</subject><subject>Nephrostomy, Percutaneous</subject><subject>percutaneous nephrostomy</subject><subject>Radical cystectomy</subject><subject>Retrospective Studies</subject><subject>Stents</subject><subject>Ureteral Neoplasms - pathology</subject><subject>Ureteral Neoplasms - surgery</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urinary Bladder Neoplasms - surgery</subject><subject>UUT recurrence</subject><issn>1558-7673</issn><issn>1938-0682</issn><issn>1938-0682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1vEzEQhi0EoqXwBzggH7lssMe7tlfiUiK-pFZUpRFHyzs72zjsR7AdJP49jlI49jT-eObVzMPYaylWUkj9brfC8R5XIKAuDwC1fMLOZatsJbSFp-XcNLYy2qgz9iKlnRB1I414zs5U24jW1OqcTbch_eTLwK8pe9zGZV4OiW_2e4r8LnrMfBOXvKUx-JGvfcQwL5Pnl0MuwCZSKeXje6Y5h_meh5nf-BzKLfEfIW_5h9H3fUHXfkaKL9mzwY-JXj3UC7b59PFu_aW6-vb56_ryqkJQJle9llYRarJQW2obGMq8xtRCqlbJtrMwGPCg0XSoUdcCBmhFp7AXplXQqQv29pS7j8uvA6XsppCQxtHPVPZzSoJV0oK2BYUTinFJKdLg9jFMPv5xUrijZrdzR83uqNmdNJemNw_5h26i_n_LP68FeH8CqGz5O1B0CYsVpD5Ewuz6JTyW_xfek41P</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Scilipoti, Pietro</creator><creator>Moschini, Marco</creator><creator>de Angelis, Mario</creator><creator>Longoni, Mattia</creator><creator>Afferi, Luca</creator><creator>Lonati, Chiara</creator><creator>Zaurito, Paolo</creator><creator>Pichler, Renate</creator><creator>Necchi, Andrea</creator><creator>Montorsi, Francesco</creator><creator>Briganti, Alberto</creator><creator>Mari, Andrea</creator><creator>Krajewski, Wojciech</creator><creator>Laukthina, Ekaterina</creator><creator>Pradere, Benjamin</creator><creator>Giudice, Francesco Del</creator><creator>Mertens, Laura</creator><creator>Gallioli, Andrea</creator><creator>Soria, Francesco</creator><creator>Gontero, Paolo</creator><creator>Albisinni, Simone</creator><creator>Shariat, Shahrokh F.</creator><creator>Carando, Roberto</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3865-5988</orcidid><orcidid>https://orcid.org/0000-0002-3316-5691</orcidid><orcidid>https://orcid.org/0000-0001-5286-9048</orcidid><orcidid>https://orcid.org/0000-0002-7768-8558</orcidid><orcidid>https://orcid.org/0000-0002-5472-1933</orcidid><orcidid>https://orcid.org/0000-0002-8953-0272</orcidid><orcidid>https://orcid.org/0000-0003-3773-3171</orcidid><orcidid>https://orcid.org/0000-0002-2613-2306</orcidid></search><sort><creationdate>202412</creationdate><title>Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer</title><author>Scilipoti, Pietro ; Moschini, Marco ; de Angelis, Mario ; Longoni, Mattia ; Afferi, Luca ; Lonati, Chiara ; Zaurito, Paolo ; Pichler, Renate ; Necchi, Andrea ; Montorsi, Francesco ; Briganti, Alberto ; Mari, Andrea ; Krajewski, Wojciech ; Laukthina, Ekaterina ; Pradere, Benjamin ; Giudice, Francesco Del ; Mertens, Laura ; Gallioli, Andrea ; Soria, Francesco ; Gontero, Paolo ; Albisinni, Simone ; Shariat, Shahrokh F. ; Carando, Roberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c237t-d6183ec6e8248e952f9507740139319b82f72a26c7bc6c6402f290b3cd07932b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Carcinoma, Transitional Cell - pathology</topic><topic>Carcinoma, Transitional Cell - surgery</topic><topic>Cystectomy</topic><topic>Double J</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hydronephrosis</topic><topic>Hydronephrosis - etiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Neoplasms, Second Primary - surgery</topic><topic>Nephrostomy, Percutaneous</topic><topic>percutaneous nephrostomy</topic><topic>Radical cystectomy</topic><topic>Retrospective Studies</topic><topic>Stents</topic><topic>Ureteral Neoplasms - pathology</topic><topic>Ureteral Neoplasms - surgery</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urinary Bladder Neoplasms - surgery</topic><topic>UUT recurrence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scilipoti, Pietro</creatorcontrib><creatorcontrib>Moschini, Marco</creatorcontrib><creatorcontrib>de Angelis, Mario</creatorcontrib><creatorcontrib>Longoni, Mattia</creatorcontrib><creatorcontrib>Afferi, Luca</creatorcontrib><creatorcontrib>Lonati, Chiara</creatorcontrib><creatorcontrib>Zaurito, Paolo</creatorcontrib><creatorcontrib>Pichler, Renate</creatorcontrib><creatorcontrib>Necchi, Andrea</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Mari, Andrea</creatorcontrib><creatorcontrib>Krajewski, Wojciech</creatorcontrib><creatorcontrib>Laukthina, Ekaterina</creatorcontrib><creatorcontrib>Pradere, Benjamin</creatorcontrib><creatorcontrib>Giudice, Francesco Del</creatorcontrib><creatorcontrib>Mertens, Laura</creatorcontrib><creatorcontrib>Gallioli, Andrea</creatorcontrib><creatorcontrib>Soria, Francesco</creatorcontrib><creatorcontrib>Gontero, Paolo</creatorcontrib><creatorcontrib>Albisinni, Simone</creatorcontrib><creatorcontrib>Shariat, Shahrokh F.</creatorcontrib><creatorcontrib>Carando, Roberto</creatorcontrib><creatorcontrib>European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</creatorcontrib><creatorcontrib>European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genitourinary cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scilipoti, Pietro</au><au>Moschini, Marco</au><au>de Angelis, Mario</au><au>Longoni, Mattia</au><au>Afferi, Luca</au><au>Lonati, Chiara</au><au>Zaurito, Paolo</au><au>Pichler, Renate</au><au>Necchi, Andrea</au><au>Montorsi, Francesco</au><au>Briganti, Alberto</au><au>Mari, Andrea</au><au>Krajewski, Wojciech</au><au>Laukthina, Ekaterina</au><au>Pradere, Benjamin</au><au>Giudice, Francesco Del</au><au>Mertens, Laura</au><au>Gallioli, Andrea</au><au>Soria, Francesco</au><au>Gontero, Paolo</au><au>Albisinni, Simone</au><au>Shariat, Shahrokh F.</au><au>Carando, Roberto</au><aucorp>European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</aucorp><aucorp>European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer</atitle><jtitle>Clinical genitourinary cancer</jtitle><addtitle>Clin Genitourin Cancer</addtitle><date>2024-12</date><risdate>2024</risdate><volume>22</volume><issue>6</issue><spage>102241</spage><pages>102241-</pages><artnum>102241</artnum><issn>1558-7673</issn><issn>1938-0682</issn><eissn>1938-0682</eissn><abstract>Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement.
We retrospectively analyzed data from 1550 patients with cTa-T3NanyM0 BCa who underwent radical cystectomy (RC) between at 12 tertiary care centers (1990-2020). Patients with complete follow-up, no prior history of UUT cancer, and who required UUT decompression for preoperative hydronephrosis were selected. Hydronephrosis grade was defined according to established scoring systems. UUT recurrence was diagnosed through imaging, urinary cytology, and confirmed by selective cytology and ureteroscopy when possible. Propensity scores were computed to determine overlap weights and balance groups. Kaplan–Meier analyses estimated UUT recurrence-free survival (RFS), cancer-specific (CSS), and overall survival (OS) before and after weighting. Cox regression analyses before and after weighting were fitted to predict UUT recurrence.
Of 524 included patients, 132 (25%) and 392 (75%) patients were managed with DJS and PCN placement, respectively. Patients who received PCN had higher grade (≥ 3) of obstruction (34% vs. 14%) and pT3-4 tumors (70% vs. 36%) than patients with DJS. During a median follow-up of 19 months, 2-years UUT-RFS did not differ between groups (95% for PCN vs 92% for DJS, weighted HR 1.41, 95% CI, 0.55-3.59). There was no difference in 2-years weighted CSS (74% vs. 74%) and OS (67% vs 69%). Main limitations were the short follow-up and inclusion of patients uniquely undergoing RC.
These results suggest that ureteral DJS does not increase the risk of developing UUT recurrence in BCa patients with hydronephrosis requiring UUT decompression. However, UUT recurrence was rare, and associations were weak, with findings susceptible to bias. Randomized trials are needed to validate these results.
Our study aims to assess if UUT decompression with Double J in patients who have hydronephrosis prior to RC, can increase the risk of UUT recurrence compared to PCN. We observed no different in the risk of subsequent UUT recurrence depending on the type of UUT management strategy, however the risk of UUT recurrence was low.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39509743</pmid><doi>10.1016/j.clgc.2024.102241</doi><orcidid>https://orcid.org/0000-0003-3865-5988</orcidid><orcidid>https://orcid.org/0000-0002-3316-5691</orcidid><orcidid>https://orcid.org/0000-0001-5286-9048</orcidid><orcidid>https://orcid.org/0000-0002-7768-8558</orcidid><orcidid>https://orcid.org/0000-0002-5472-1933</orcidid><orcidid>https://orcid.org/0000-0002-8953-0272</orcidid><orcidid>https://orcid.org/0000-0003-3773-3171</orcidid><orcidid>https://orcid.org/0000-0002-2613-2306</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1558-7673 |
ispartof | Clinical genitourinary cancer, 2024-12, Vol.22 (6), p.102241, Article 102241 |
issn | 1558-7673 1938-0682 1938-0682 |
language | eng |
recordid | cdi_proquest_miscellaneous_3128318268 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Carcinoma, Transitional Cell - pathology Carcinoma, Transitional Cell - surgery Cystectomy Double J Female Follow-Up Studies Humans Hydronephrosis Hydronephrosis - etiology Male Middle Aged Neoplasms, Second Primary - pathology Neoplasms, Second Primary - surgery Nephrostomy, Percutaneous percutaneous nephrostomy Radical cystectomy Retrospective Studies Stents Ureteral Neoplasms - pathology Ureteral Neoplasms - surgery Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery UUT recurrence |
title | Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A46%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Metachronous%20Upper%20Tract%20Urothelial%20Carcinoma%20After%20Ureteral%20Stenting%20in%20Patients%20With%20Bladder%20Cancer&rft.jtitle=Clinical%20genitourinary%20cancer&rft.au=Scilipoti,%20Pietro&rft.aucorp=European%20Association%20of%20Urology%20-%20Young%20Academic%20Urologists%20(EAU-YAU),%20Urothelial%20carcinoma%20working%20group&rft.date=2024-12&rft.volume=22&rft.issue=6&rft.spage=102241&rft.pages=102241-&rft.artnum=102241&rft.issn=1558-7673&rft.eissn=1938-0682&rft_id=info:doi/10.1016/j.clgc.2024.102241&rft_dat=%3Cproquest_cross%3E3128318268%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128318268&rft_id=info:pmid/39509743&rft_els_id=S1558767324002118&rfr_iscdi=true |